Penczek Ronald W's Form 4 filing
Elevance Health, Inc. (ELV) · filed Mar 3, 2022
- Accession no.
- 0001156039-22-000025
- Filed
- Mar 3, 2022
- Trade date
- Mar 1-3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.12M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Penczek Ronald WCIK 0001659075 | Officer (CAO & Controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | FTax withholdingDisposed | −369 | $451.50 | −$166,603.5 | 1,643 | Direct | |
| Mar 1, 2022 | Common Stock | AGrant or awardAcquired | +222 | $0.00 | $0 | 1,865 | Direct | |
| Mar 1, 2022 | Common Stock | AGrant or awardAcquired | +953 | $0.00 | $0 | 2,818 | Direct | |
| Mar 2, 2022 | Common Stock | FTax withholdingDisposed | −52 | $463.49 | −$24,101.48 | 2,766 | Direct | |
| Mar 3, 2022 | Common Stock | MOption exerciseAcquired | +438 | $311.48 | +$136,428.24 | 3,204 | Direct | |
| Mar 3, 2022 | Common Stock | MOption exerciseAcquired | +653 | $271.27 | +$177,139.31 | 3,857 | Direct | |
| Mar 3, 2022 | Common Stock | MOption exerciseAcquired | +468 | $307.68 | +$143,994.24 | 4,325 | Direct | |
| Mar 3, 2022 | Common Stock | SSaleDisposed | −2,423 | $463.68F4 | −$1,123,496.64 | 1,902 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Common Stock | AGrant or awardAcquired | +882 | $0.00 | $0 | 882 | Direct | |
| Mar 3, 2022 | Common Stock | MOption exerciseDisposed | −438 | $0.00 | $0 | 877 | Direct | |
| Mar 3, 2022 | Common Stock | MOption exerciseDisposed | −653 | $0.00 | $0 | 654 | Direct | |
| Mar 3, 2022 | Common Stock | MOption exerciseDisposed | −468 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
This transaction was executed in multiple trades at prices ranging from $463.57 to $463.73. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.